PASTA probes: Defining the role of the PASTA kinase Stk1 in S. aureus virulence gene expression using a chemical biology approach
PASTA probes: Defining the role of the PASTA kinase Stk1 in S. aureus virulence gene expression using a chemical biology approach
批准号:
9813183
负责人:
Meghan Scobee Blackledge
金额:
$41.18万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-01 至 2022-09-19
关键词:
AdjuvantAffectAnti-Bacterial AgentsAntibiotic ResistanceAntibioticsAttenuatedBacteriaBacterial Antibiotic ResistanceBacterial InfectionsBasic ScienceBindingBinding SitesBiological AssayBiological ProcessBiologyCarbazolesCell WallChemicalsChemosensitizationDataDevelopmentDrug TargetingEvaluationGene ExpressionGene Expression RegulationGene ProteinsGenesGenetic TranscriptionGoalsHomeostasisIn VitroInfectionKnowledgeLeadMapsMeasurableMediatingMedicalMicrobial BiofilmsMissionModelingMolecularMonobactamsNational Institute of General Medical SciencesOutcomePathway interactionsPenicillin-Binding ProteinsPenicillinsPhenotypePhosphorylationPhosphotransferasesPredispositionPreventionProteinsProteomicsPublic HealthRegulatory PathwayResearchRoleSerineStaphylococcus aureusStaphylococcus aureus infectionStructureStructure-Activity RelationshipThreonineToxinTranscriptional RegulationUnited States National Institutes of HealthVariantVirulenceVirulentadvanced diseasebasebeta-Lactamscombatdesignextracellularin vivoinhibitor/antagonistinsightmethicillin resistant Staphylococcus aureusmutantnew therapeutic targetnovelnovel therapeuticspreventresistant strainscreeningsmall moleculetherapeutic targettooltranscriptomics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
The regulatory kinase Stk1 controls genes involved in antibiotic resistance, biofilm formation, and toxin
expression in virulent strains of Staphylococcus aureus. Inhibition of Stk1 in vitro potentiates methicillin-resistant
S. aureus (MRSA) to b-lactam antibiotics and inhibits biofilm formation, making it an attractive target for the
development of novel antibiotic adjuvant and antibiofilm therapies. However, studies of stk1 deletion mutants
in vivo have many raised questions about the role of Stk1 in infection. In some MRSA strains and infection
models, deletion of stk1 attenuates infection, whereas in other models and strains the stk1 deletion mutant
displays enhanced virulence. Because only a few substrates of Stk1 have been identified, it is difficult to predict
the full consequences of Stk1 inhibition. Additionally, strain-specific differences in the downstream genes whose
expression is affected by Stk1 phosphorylation has prevented comprehensive understanding of Stk1-mediated
gene expression in S. aureus. Our long-term goal is to develop novel anti-virulence treatments to combat
persistent and antibiotic resistant bacterial infections. Our overall objectives in this proposal are to develop Stk1
inhibitors as chemical probes that can identify strain-specific differences in Stk1 inhibition and expand our
knowledge of Stk1-mediated virulence gene expression in medically-relevant strains of S. aureus. Specifically,
we will use our designed chemical probes to interrogate the inhibitor binding site of Stk1 across several strains
of S. aureus to elucidate strain-specific differences that could affect development of broadly active inhibitors.
Lead probes will then be used to identify novel antibiotic classes whose susceptibility is affected by Stk1 activity.
Finally, we will use a combined transcriptomic and proteomic approach to identify novel Stk1 substrates and
map downstream genes whose expression is affected by Stk1. Together, this will enhance existing knowledge
of virulence pathways and their regulatory mechanisms in S. aureus. These results will have a significant impact
as they will expand our understanding of gene regulation in S. aureus and provide necessary information for
evaluation of Stk1 as a therapeutic target, thereby providing crucial new information for the development of
novel antibacterial therapies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金